Prostate Cancer - Results from #18980

Androgen deprivation therapy, cardiovascular risk, and multidisciplinary management of the prostate cancer patient: A German perspective - Session Highlights March 17, 2015

Magnetic resonance imaging-guided prostate biopsy: Present and future - Abstract March 16, 2015

Quality improvement process to assess tattoo alignment, set-up accuracy and isocentre reproducibility in pelvic radiotherapy patients - Abstract March 16, 2015

The quality assurance of volumetric modulated arc therapy (VMAT) plans for early stage prostate cancer: A technical not - Abstract March 16, 2015

Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer - Abstract March 14, 2015

Imagery of treated prostate cancer - Abstract March 14, 2015

Efficacy of flutamide-combined androgen blockade therapy in advanced prostate cancer patients: A phase III randomized, comparative trial - Abstract March 14, 2015

Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer - Abstract March 13, 2015

Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement - Abstract March 13, 2015

Word on the street: Engaging local leaders in a dialogue about prostate cancer among African Americans - Abstract March 13, 2015

Imaging biomarkers in prostate cancer: Role of PET/CT and MRI - Abstract March 13, 2015

Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer - Abstract March 13, 2015

Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer - Abstract March 13, 2015

Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: A propensity score matched analysis - Abstract March 13, 2015

Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: Analysis of data from the RADAR Prostate Radiation Therapy trial - Abstract March 13, 2015

Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies - Abstract March 13, 2015

18F-Fluoride PET used for treatment monitoring of systemic cancer therapy: Results from the National Oncologic PET Registry - Abstract March 13, 2015

ADT risks and side effects in advanced prostate cancer: Cardiovascular and acute renal injury - Abstract March 12, 2015

Chronic inflammatory mediators enhance prostate cancer development and progression - Abstract March 12, 2015

Improvements in radiographic progression-free survival stratified by ERG gene status in castration-resistant prostate cancer patients treated with abiraterone - Abstract March 12, 2015

Page 950 of 1458